Matthew H. Wilson

Heterozygous alpha 2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists.

Functional zinc finger/sleeping beauty transposase chimeras exhibit attenuated overproduction inhibition.

PiggyBac transposon-mediated gene transfer in human cells.

Genome-wide mapping of PiggyBac transposon integrations in primary human T cells.

Optimization of the PiggyBac transposon system for the sustained genetic modification of human T lymphocytes.

PiggyBac transposon-based inducible gene expression in vivo after somatic cell gene transfer.

piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies.

Multiplexed transposon-mediated stable gene transfer in human cells.

Designing and testing chimeric zinc finger transposases.

Manipulating piggyBac transposon chromosomal integration site selection in human cells.

PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor.

Combining mTor inhibitors with rapamycin-resistant T cells: a two-pronged approach to tumor elimination.

Hyperactive piggyBac gene transfer in human cells and in vivo.

Loss of glutathione S-transferase A4 accelerates obstruction-induced tubule damage and renal fibrosis.

Evaluating the potential for undesired genomic effects of the piggyBac transposon system in human cells.

piggyBac-ing models and new therapeutic strategies.

Neurosarcoidosis Presenting as Aseptic Meningitis in an Immunosuppressed Renal Transplant Recipient.

Temporal self-regulation of transposition through host-independent transposase rodlet formation.